2023
DOI: 10.3390/pharmaceutics15020621
|View full text |Cite
|
Sign up to set email alerts
|

Cell-Membrane-Coated Nanoparticles for Targeted Drug Delivery to the Brain for the Treatment of Neurological Diseases

Abstract: Neurological diseases (NDs) are a significant cause of disability and death in the global population. However, effective treatments still need to be improved for most NDs. In recent years, cell-membrane-coated nanoparticles (CMCNPs) as drug-targeting delivery systems have become a research hotspot. Such a membrane-derived, nano drug-delivery system not only contributes to avoiding immune clearance but also endows nanoparticles (NPs) with various cellular and functional mimicries. This review article first prov… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
14
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 33 publications
(14 citation statements)
references
References 150 publications
0
14
0
Order By: Relevance
“…Another challenge is the potential for off-target effects, as exosomes can be taken up by cells other than the intended target cells. 113 , 114 Furthermore, the heterogeneity of exosomes derived from different cell types can make it difficult to compare and interpret results from different studies.…”
Section: Cell-based Nanoparticle Drug Delivery Strategies For Overcom...mentioning
confidence: 99%
“…Another challenge is the potential for off-target effects, as exosomes can be taken up by cells other than the intended target cells. 113 , 114 Furthermore, the heterogeneity of exosomes derived from different cell types can make it difficult to compare and interpret results from different studies.…”
Section: Cell-based Nanoparticle Drug Delivery Strategies For Overcom...mentioning
confidence: 99%
“…For example, peptide- and antibody-based targeting strategies are currently used in oncotherapy to deliver drugs to tumor cells or tissues. 188 Synthesizing antibody-drug conjugates consist of the antibody, which targets an antigen exposed at the cell surface, chemically linked to the active therapeutic agent, known as the warhead. However, this approach is currently limited to highly potent drugs, given the large size of antibodies that gives a low loading efficiency.…”
Section: Piezo Channels As Therapeutic Targets?mentioning
confidence: 99%
“…185,186 To capitalize on the ability of macrophages to access the brain, researchers have developed a novel approach using macrophage membrane-coated nanoparticles (MM-NPs). 187 These nanoparticles are enveloped by membranes derived from macrophages, effectively mimicking the surface properties of these immune cells. 188 Under conditions such as brain inflammation, chemokines like CCL19 or CCL20 play a pivotal role in recruiting immune cells, including macrophages, to the affected area.…”
Section: Viral Inspired Approachmentioning
confidence: 99%
“…Macrophage is a type of immune cell, possess the ability to migrate into the brain under specific circumstances, particularly during inflammatory processes. , To capitalize on the ability of macrophages to access the brain, researchers have developed a novel approach using macrophage membrane-coated nanoparticles (MM-NPs) . These nanoparticles are enveloped by membranes derived from macrophages, effectively mimicking the surface properties of these immune cells .…”
Section: Biomimetic Approaches For Cns Diseasesmentioning
confidence: 99%